CA2298762C

CA2298762C - Therapeutic compositions consisting of clarified multi-filtered soluable sodium silicate in liquid form are found to modify suppressor cells and enhanse the human immune system toprevent recurrence of herpes infections

Info

Publication number: CA2298762C
Application number: CA002298762A
Authority: CA
Inventors: Paul M. Pidcock
Original assignee: Individual
Current assignee: Individual
Priority date: 2000-02-11
Filing date: 2000-02-11
Publication date: 2001-06-12
Anticipated expiration: 2020-02-11
Also published as: CA2298762A1

Abstract

This discovery and invention relates to a therapeutic composition of matter which may be used for the home treatment of herpes-caused cutaneous infections whereby the formation of new lesions is prevented. The preferred composition comprises a liquid which is a clarified, multi-filtered soluble sodium silicate in which the minerals are suspended in an aqueous solution. Application to the infection is found to modify the suppressor cells and such enhanses the immune system. This new therapy is a remarkable improvement to the present art for treatment of Herpes viruses as the disease symptoms disappear permanently while existing treatments only reduce the severity of the disease. Up to this time there has not been an established, efficient practical product or method to permanently prevent the recurrence of Herpes lesions.

Description

SPECIFICATION
This invention relates to the field of medical therapeutics and specifically that class which deals with lesions of the skin caused by Herpes viruses.
Processes previously known and used included many topical analgesics which were not singularly effective. While some tablets based on Acyclovir reduced the severity of the disease, they require lifetime use and do not result in permanent l, elimination of lesions.
This invention provides a patient administered substance which overcomes the previous shortcomings and is simple to apply. It promotes improved healing time with no scarring of the skin 15 and reduces the opportunity for entry of other infective agents. Additionally it has no side effects, is not carcinogenic to humans and is rated GRAS
(generally regarded as safe) by the Food and Drug Administration. A major advantage to be attained will be the low cost of distribution as the substance is already in bulk supply at a few cents per ounce.
The background of the disease is outlined to afford a better understanding of the nature of the invention. A cure has escaped the best medical z5 research efforts for the last twenty years. The family of Herpes viruses has been affecting animals for many years but reached epidemic proportions in Humans in the early 1980's. There are five major types infecting humans and demonstrate six so stages of infection from prodrome to replacement of the scabs by new cells. It is estimated , as Herpes is not a reportable disease, that some 60 million Americans are infected with the disease and one hundred thousand new cases develop annually.
Some estimates suggest that 50 % of the world s population is affected with some of the under-developed countries reporting much higher figures.
I have a number of documented reports that a single treatment with aqueous sodium silicate eliminates the recurrence of Herpes lesions. In to several cases where an immunodeficiency was present , it required additional treatment where a second but much smaller lesion appeared.
Normally, the immune system requires about seven days to produce an adequate level of antibodies. By 15 that time it is too late as the viruses have invaded skin cells and through parasitic action have utilized cell DNA to reproduce and cause highly infective lesions. The basic substance discovered to cure herpes infections is a liquid formation, being a soluble sodium silicate, available from National Zo Silicates Ltd. of Toronto, Ontario and fully described in their Bulletin 17-1.
The substance has been used in commercial applications for over 100 years. The only medical 25 use todate is to control bacteria in eggs and washing meat products. Its use as a cure for Herpes is a new discovery and superior to substances previously used in the medical profession.
so Experimentation which lead to the discovery was as follows;
Mid-1980's testing on Human volunteers showed no recurrence of the symptoms of Herpes ,neither has there been any recurrence in these cases after 15 years.
In-vitro testing was done by USA 's N.I.H. of Bethesda , Maryland, USA under a secrecy agreement. This was carried out at the University of Birmingham , USA and showed some suseptability but clearly demonstrated that the presence of the immune system is essential . Upon search of the Canadian patent database, no patents were found matching my query utilizing "Herpes viruses" and ' sodium silicate" A similar search of the US. Patent and TM office showed no matching of the query. A second Canadian search utilizing "Herpes and " Infection " was matched in 15 57 out of 1,419.762 patents. In study of these 57 patents, there was no reference to sodium silicate.
Search of a specific patent (USA) (Birchall) , (#
5,814,347 ) which claims lithium silicate as a zc treatment for Herpes infections. It mixes several substances such as carbonates, talc , silica and sodium silicate and utilizes them as drying agents.
This, in my opinion, does not conflict with my discovery which teaches that a single, liquid z5 solution of sodium silicate applied to the infections moderates the immune system in such a way to prevent the recurrence of lesions..permanently.
~~F-DRAWINGS
Since the invention is not suitable for proper description by drawings, included are copies of illustrations of 1. The structure and life cycle of the virus , and 11. The natural process of the human immune ststem. The explanation as to why the discovered substance effectively prevents the recurrence of lesions is not well understood at this time and extensive to additional research will have to be carried out to confirm reasons. However, from results from human tests, there can be no explanation other than that the immune system has been enhanced to maintain an adequate level of 15 antibodies to maintain the dormant viruses inactive. Additionally, the mechanical features of the substance may coat skin cells and prevent escape of viruses from infected cells.
_5_

Claims

The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows:

CLAIM 1. A therapeutic composition of matter, consisting of an aqueous sodium silicate solution, may be utilized for the treatment of Herpes infections thereby blocking the virus and preventing new lesion formation.